Article

Combined BRCA2 and MAGEC3 expression predict outcome in Advanced Ovarian Cancers

2022-08-18

Abstract excerpt

Like BRCA2, MAGEC3 is an ovarian cancer predisposition gene that has been shown to have prognostic significance in ovarian cancer patients. Despite the clinical significance of each individual gene, no studies have been done to assess the clinical significance of their combined expression. We therefore sought to determine the relationship between MAGEC3 and BRCA2 expression in ovarian cancer and their association...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 697882a2-47a0-5c5b-9a3d-162106943883
DOI: 10.1101/2022.08.17.22278635

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 8 closest

Combined BRCA2 and MAGEC3 expression predict outcome in Advanced Ovarian CancersDOI 10.1101/2022.08.17.22278635Read

MAGEC3 is a prognostic biomarker in ovarian and kidney cancersSemantic proximity Read

Aquaporin 3 Expression Predicts Survival in Patients with HER2-positive Early Breast Cancer.Semantic proximity Read

CDKN3 is an independent prognostic factor and promotes ovarian carcinoma cell proliferation in ovarian cancerSemantic proximity Read

Aberrations of TACC1 and TACC3 are associated with ovarian cancerSemantic proximity Read

The melanoma-associated antigen-A3, -A4 genes: relation to the risk and clinicopathological parameters in breast cancer patients.Semantic proximity Read

Expression of the Immune Checkpoints LAG-3 and PD-L1 in High-grade Serous Ovarian Carcinoma: Relationship to Tumor-associated Lymphocytes and Germline BRCA StatusSemantic proximity Read

Detection of MAGE-A3 in breast cancer patients' sentinel lymph nodes.Semantic proximity Read

Genetic variants and expression of the TIM-3 gene are associated with clinical prognosis in patients with epithelial ovarian cancer.Semantic proximity Read